Although some studies have suggested that β2-M alone may have limited diagnostic utility in HIV-NHL [142], recent clinical data indicate that elevated serum β2-M is directly associated with increased tumor cell proliferation and tumor burden [143]. The gene discussed is B2M; the disease is non-Hodgkin lymphoma.